9 Meters Biopharma, Inc.

"BIOPHARMA"

Class 042: Pharmaceutical research and development services; Medical and scientific research information in the field of novel pharmaceutical discovery and development; Research and development in the pharmaceutical and biotechnology fields; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Medical and scientific research, namely, conducting clinical trials for others of New Therapeutic Entities (NTEs) defined as pharmacological treatments based on molecules that are already approved for other indications that are neither New Chemical Entities (NCEs) nor generics and New Chemical Entities (NCEs) and Biologic License Application (BLAs) as novel pharmaceutical treatments; Research and development in the field of New Therapeutic Entities (NTEs) defined as pharmacological treatments based on molecules that are already approved for other indications that are neither New Chemical Entities (NCEs) nor generics and New Chemical Entities (NCEs) and Biologic License Application (BLAs) as novel pharmaceutical treatments; Research and development in the field of novel pharmaceutical treatments and clinical trials; Providing medical and scientific research information in the field of novel pharmaceutical treatments and clinical trials; Clinical trials services for others

Pharmaceutical research and development services; medical and scientific research information in the field of novel pharmaceutical discovery and development; research and development in the pharmaceutical and biotechnology fields; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical and scientific research, namely, conducting clinical trials for others of new therapeutic entities (NTEs) defined as pharmacological treatments based on molecules that are already approved for other indications that are neither new chemical entities (NCEs) nor generics and new chemical entities (NCEs) and biologic license application (BLAs) as novel pharmaceutical treatments; research and development in the field of new therapeutic entities (NTEs) defined as pharmacological treatments based on molecules that are already approved for other indications that are neither new chemical entities (NCEs) nor generics and new chemical entities (NCEs) and biologic license application (BLAs) as novel pharmaceutical treatments; research and development in the field of novel pharmaceutical treatments and clinical trials; providing medical and scientific research information in the field of novel pharmaceutical treatments and clinical trials; clinical trials services for others; all of the foregoing related to celiac disease